These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8837307)

  • 1. Oligonucleotide ligation assay for detection of the factor V mutation (Arg506-->Gln) causing protein C resistance.
    Benson JM; Phillips DJ; Holloway BP; Evatt BL; Hooper WC
    Thromb Res; 1996 Jul; 83(1):87-96. PubMed ID: 8837307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated system.
    Zotz RB; Maruhn-Debowski B; Scharf RE
    Thromb Haemost; 1996 Jul; 76(1):53-5. PubMed ID: 8819251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
    Aparicio C; Dahlbäck B
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fast and robust dual-label nonradioactive oligonucleotide ligation assay for detection of factor V Leiden.
    Chakravarty A; Hansen TS; Hørder M; Kristensen SR
    Thromb Haemost; 1997 Oct; 78(4):1234-6. PubMed ID: 9364990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
    Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V R506Q gene mutation analysis by PCR-RFLP: optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls.
    Voelkerding KV; Wu L; Williams EC; Hoffman SM; Sabatini LM; Borcherding WR; Huber S
    Am J Clin Pathol; 1996 Jul; 106(1):100-6. PubMed ID: 8701917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations.
    Kodaira H; Ishida F; Shimodaira S; Takamiya O; Furihata K; Kitano K
    Acta Haematol; 1997; 98(1):22-5. PubMed ID: 9210909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
    Dahlbäck B
    Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation (g2172-->c) in the factor V gene in a Chinese family with hereditary activated protein C resistance.
    Cai H; Hua B; Fan L; Wang Q; Wang S; Zhao Y
    Thromb Res; 2010 Jun; 125(6):545-8. PubMed ID: 20304467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B
    Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia as a multigenic disease.
    Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
    Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance.
    Kirschbaum NE; Foster PA
    Thromb Haemost; 1995 Sep; 74(3):874-8. PubMed ID: 8571314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial thrombophilia: clinical and molecular analysis of Swedish families with inherited resistance to activated protein C or protein S deficiency.
    Zöller B
    Scand J Clin Lab Invest Suppl; 1996; 226():19-46. PubMed ID: 8981666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A colorimetric minisequencing assay for the mutation in codon 506 of the coagulation factor V gene.
    Sitbon G; Hurtig M; Palotie A; Lönngren J; Syvänen AC
    Thromb Haemost; 1997 Apr; 77(4):701-3. PubMed ID: 9134646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple and reliable factor V genotyping by PNA-mediated PCR clamping.
    Behn M; Schuermann M
    Thromb Haemost; 1998 Apr; 79(4):773-7. PubMed ID: 9569191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis strategies in activated protein C resistance: is genotyping still necessary?
    Biron C; Lamarti H; Schved JF; Jeanjean P; Masmejean C; Claustres M; Aguilar-Martinez P
    Clin Lab Haematol; 1997 Mar; 19(1):67-71. PubMed ID: 9146951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.